HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.

AbstractOBJECTIVE:
The apolipoprotein (apo)A-I mimetic peptide 5A is highly specific for ATP-binding cassette transporter (ABC)A1-mediated cholesterol efflux. We investigated whether the 5A peptide shares other beneficial features of apoA-I, such as protection against inflammation and oxidation. Methods- New Zealand white rabbits received an infusion of apoA-I, reconstituted high-density lipoprotein (HDL) containing apoA-I ([A-I]rHDL), or the 5A peptide complexed with phospholipids (1-palmitoyl-2-linoleoyl phosphatidylcholine [PLPC]), before inserting a collar around the carotid artery. Human coronary artery endothelial cells (HCAECs) were incubated with (A-I)rHDL or 5A/PLPC before stimulation with tumor necrosis factor alpha. Results- ApoA-I, (A-I)rHDL, and 5A/PLPC reduced the collar-mediated increase in (1) endothelial expression of cell adhesion molecules vascular cell adhesion molecule-1 and intercellular adhesion molecule-1; (2) production, as well as the expression of the Nox4 catalytic subunits of the NADPH oxidase; and (3) infiltration of circulating neutrophils into the carotid intima-media. In HCAECs, both 5A/PLPC and (A-I)rHDL inhibited tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression, as well as the nuclear factor kappaB signaling cascade and production. The effects of the 5A/PLPC complex were no longer apparent in HCAECs knocked down for ABCA1.
CONCLUSIONS:
Like apoA-I, the 5A peptide inhibits acute inflammation and oxidative stress in rabbit carotids and HCAECs. In vitro, the 5A peptide exerts these beneficial effects through interaction with ABCA1.
AuthorsFatiha Tabet, Alan T Remaley, Aude I Segaliny, Jonathan Millet, Ling Yan, Shirley Nakhla, Philip J Barter, Kerry-Anne Rye, Gilles Lambert
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 30 Issue 2 Pg. 246-52 (Feb 2010) ISSN: 1524-4636 [Electronic] United States
PMID19965776 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ABCA1 protein, human
  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters
  • Anti-Inflammatory Agents
  • Antioxidants
  • Apolipoprotein A-I
  • Lipoproteins, HDL
  • NF-kappa B
  • Peptides
  • Phosphatidylcholines
  • RNA, Messenger
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Vascular Cell Adhesion Molecule-1
  • Superoxides
  • Intercellular Adhesion Molecule-1
  • 1-palmitoyl-2-linoleoylphosphatidylcholine
  • NADPH Oxidases
Topics
  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters (genetics, metabolism)
  • Adult
  • Animals
  • Anti-Inflammatory Agents (administration & dosage, metabolism, pharmacology)
  • Antioxidants (administration & dosage, metabolism, pharmacology)
  • Apolipoprotein A-I (administration & dosage, metabolism, pharmacology)
  • Carotid Arteries (drug effects, metabolism, pathology)
  • Carotid Artery Diseases (drug therapy, metabolism, pathology)
  • Cells, Cultured
  • Disease Models, Animal
  • Endothelial Cells (drug effects, metabolism)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Humans
  • Intercellular Adhesion Molecule-1 (metabolism)
  • Lipoproteins, HDL (metabolism)
  • Male
  • Molecular Mimicry
  • NADPH Oxidases (genetics, metabolism)
  • NF-kappa B (metabolism)
  • Neutrophil Infiltration (drug effects)
  • Peptides (administration & dosage, metabolism, pharmacology)
  • Phosphatidylcholines (metabolism)
  • RNA Interference
  • RNA, Messenger (metabolism)
  • Rabbits
  • Recombinant Proteins (metabolism)
  • Signal Transduction (drug effects)
  • Superoxides (metabolism)
  • Time Factors
  • Transfection
  • Tumor Necrosis Factor-alpha (metabolism)
  • Vascular Cell Adhesion Molecule-1 (metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: